HMOX1 and myeloid sarcoma: Van Horssen et al. reported a marked upregulation of the antioxidant enzymes superoxide-dismutases 1 and 2, catalase, heme oxygenase 1, and NAD(P)-quinone oxidoreductase 1 in active demyelinating MS lesions [108] in MS patients when compared with healthy controls.